Chrys Kokino serves as the President of US Specialty at Accord Healthcare, where he is spearheading an ambitious growth strategy in the U. S. biosimilars market. He holds an MBA from Golden Gate University and has a background in global commercialization from previous leadership roles at Mylan, Sandoz, and Roche.
He is a proponent of patient advocacy and community health awareness. This is demonstrated by his leadership in launching campaigns like "PRO-STATE of Mind, " which encourages open conversations and the importance of early detection for prostate cancer.
He recently led the strategic acquisition of the UDENYCA® (pegfilgrastim-cbqv) business, significantly expanding Accords commercial portfolio and workforce.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.